Point-of-Care Testing (POCT) Market Size, Share, and Trends 2024 to 2034

Point-of-Care Testing (POCT) Market (By Product Type: Covid -19 testing kits, Glucose monitoring products, Infectious disease testing products, Coagulation monitoring products, Pregnancy and fertility testing products, Others; By Platform: Lateral flow assays, Dipsticks, Microfluids, Molecular Diagnostics, Immunoassays; By Mode of Purchase: OTC products, Prescribed based products; By Testing Type; By End-User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : June 2023
  • Report Code : 2270
  • Category : Healthcare

The global point-of-care testing (POCT) market size was estimated at USD 35.33 billion in 2023 and is expected to reach around USD 99.33 billion by 2032 with an increasing CAGR of 12.2% from 2023 to 2032 due to increasing demands from the market due to increasing disorders among the population.

Point-of-Care Testing Market Size 2023 To 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America was accounted highest revenue share more than 46% in 2022.
  • Asia Pacific POCT market is registering at a CAGR of 9.8% from 2023 to 2032.
  • By product, glucose monitoring products segment has captured highest revenue share 27% in 2022. 
  • By platform, lateral flow assays segment has accounted 36% revenue share in 2022.
  • By mode of purchase, OTC testing products segment has held 59% revenue share in 2022.
  • The glucose monitoring segment was valued at USD 8.91 billion in in 2022.
  • The biosensors segment is growing a CAGR of 9.2% during the frorecast period.
  • The pregnancy and fertility testing products segment is expected to reach at a 8.1% of CAGR from 2023 to 2032.
  • The diagnostic centers segment is growing at a CAGR of 7.8% over the forecast period.

Point-of-care testing markets are basically utilised for diagnosis of the disorder by performing various tests at the proper place and the proper time with increased facilities for testing the disorder with the availability of the testing kits available in the market. Point-of-care test markets are very normal tests and easy that can patient itself also can perform the test sitting at one place. Developing technologies in the medical sector with the aim of patients health and increased demands from the medical sector with rising disorders among the population and for fast treatment and quick diagnosis of the disorder available for quick treatment to the patients.

Diagnostic kits such as urine test strips available in the market for detecting the disorder or any problem. Pulse oximetery the electronic device that patient can check the oxygen level sitting at home and many more test are performed and in the laboratory with increased demands for glucose check, haemoglobin check and more mover. Which helped to expand the market of point care testing market.

Impact of COVID-19 on the point of  care testing market rate with increased market revenue share due increasing number of patients with the viral infection and wide spread of corona virus affecting the patients health with increased demands from the medical sector for rapid testing and antigen testing of the patient and increased demands for blood testing, x-ray and many more test which are required for detecting the spread of disease with improved number of diagnostic procedure available which help to enhance the market of point care testing market.

Point-of-Care Testing (POCT) Market Scope

Report Coverage Details
Market Size in 2023

USD 35.33 Billion

Market Size by 2032

USD 99.33 Billion

Growth Rate from 2023 to 2032 CAGR of 12.2%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product Type, Platform, Mode of Purchase, Testing Type, End-User, and Geography
Companies Mentioned Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Johnson & Johnson, Danaher Corporation, Becton, Dickinson and Company (BD), Philips Healthcare, Sysmex Corporation, Quidel Corporation, Chembio Diagnostics

Growth Factors

Point-of-care testing are the medical devices utilized for diagnosis of the disorder and faster results with increased efficiency and accuracy of the diagnostic kits with increased demands from the market so that people sitting at home any time any place can access the kit with quick results and fast treatment with the increased focus with increasing care of the patient and enhance the market growth of market due to increased demands.

Increasing prevalence of chronic disorders among the patients with disorders such as cancer, diabetes, arthritis, cardiovascular disorder and other with increased medical diagnostic kits available in the market and increased number of patients for testing purpose with increased technology and developed techniques in point-of-care testing market with increased research and development with new innovative techniques involved with increased software system and increased connectivity for performing the tests led to enhance the market rate of point care testing market.

The use of different point-of-care testing procedures and devices available in the market with different disorder accelerate the market. The key market players involved in the introduction of new launches in medical diagnostic kits with increased research and development and increased investment from the key market players help to grow the market of market. Increased interference of the government with increased funding for research and development of new techniques and enhance number of policies of reimbursement helps to drive the market.

The outbreak of COVID-19 with increased spread of corona virus with positive and negative impact on the point care testing market with increased demands from the health sector with rising patients which propel the point-of-care testing market at increased CAGR rate.

Point-of-Care Testing (POCT) Market Dynamics

Key Market Drivers

  • Enhance prevalence of chronic disorders - Increasing number of disorders among the population with changing modern life style, dietary intake, obesity, lack of exercise led to increasing number of disorders and increased utilization of diagnostics kits and increased efficiency of the diagnostic kits with increased accuracy of the test drives the market of point care testing market. Chronic disorders such as diabetes, oncology, cardiovascular, arthritis, respiratory disorder and many more. Increased research and development with new technologies integrated in the medical sector and supply of needs required for curing the patients health with quick relief and quick results helps to drive the market of point care testing market.
  • Developing infrastructure and health care facilities - Huge number of people with chronic disorders and increased demands from the market for medical diagnostic kits with increased technology and techniques involved for carrying out the procedures in the laboratory or at home with ease of access to the medical devices for detecting of the problem. Improved number of health facilities in the hospital with newly developed technologies and improved research and technology with new launches by the key market players helps to accelerate the market of market.

Key Market Challenges 

  • The rising cost of the point care testing medical devices - The rapid advance technologies developed in the market with increased production and manufacturing of the medical devices utilized in the hospitals for detection of the various disorders with increased efficiency and accuracy of the testing kit which led to increased cost of the testing procedures with newly developed testing kits. Enhance cost of the medical diagnostic devices can challenge the market to grow at higher value
  • Lack of skill - The increasing medical diagnostic technologies in the market with improved techniques with software system embedded in to the devices which are installed in the hospital with increased connectivity. The new techniques require new skills lack of skill among the individuals enable to perform the medical diagnostic procedure. which may hamper the market rate of market 

Key Market Opportunities

  • Emerging underdeveloped regions with new developments and rising disorder - The rapid acceptance of the newly developed technologies in medical diagnostics for and enhance testing with improved technologies in the point care testing with increased efficiency and accuracy of the test. Development of point care testing across various regions with increased necessity of the testing kits drives the market of market to a larger extend with increased market share during the forecast period.
  • Government interference with increased facilities - Increased government interference in the Point-of-care testing market with increased installation of the medical devices required for diagnosis of the disorder and increased providence from the government of various regions for introducing new techniques and technologies in Point-of-care testing market. Increased government policies such as reimbursement so that every individual can opt for the new devices developed and can able to the benefit. Which helps to accelerate the growth of market at considerable height.  
  • The key market players - Wide research and development programs carried out by the key market players with increasing investment for introducing new medical diagnostic kits with improved efficiency and efficacy with improved results and good response from the customer has emerged to be the major opportunity which helps to boost the market of point-of-care testing market during the forecast period.

Product Type Insights

On the basis of product type, glucose monitoring product to hold the largest market share globally with increased demands from the customer with increasing disorders among the population and enhance demands for glucose monitoring product. Utilisation of glucose monitoring product use to determine the glucose level in individual which provides the information of insulin release in the body.

Glucose monitoring device is self-accessible to prick with needle on finger and collection of samples on the device and provides the information of glucose levels in the patients body. Utilisation of the point care testing with increased demands for the glucose monitoring device from the customer with diabetes-I and diabetes-II.

Platform Insights

On the basis of platform, lateral flow assay with highest market value in point care testing market. Increased analysis of the sample by immunochromatographic techniques for detection of analytes in the sample with detecting and quantifying of complex samples and submitting the results less than 30min period of time. Increased acceptance of the developed platforms and lateral flow assay test with conventual procedures performed in the labs helps to expand the market of Point-of-care testing market.

End-Users Insights

On the basis of end users, clinical laboratories accounted for the largest market share with increasing number of chronic disorder and increased utilization of testing sample in the laboratories. Covid-19 with wide spread of virus and increase in development of the testing and made available in the laboratories so that the individual can examine the presence of virus with enhance requirements from the market for point-of-care testing market. The home care testing services which are self-tested with highest market with increasing CAGR helps to drive the market.

Regional Insights

On the basis of geography, North America with highest market with increased CAGR in point-of-care testing market with increasing disorder among the population and increased demands for medical diagnostic kits with quick detection of the disorder and fast treatment increase the market revenue share of point-of-care test with developed technology with continuous research helps to drive the market.

Point-of-Care Testing Market Share, By Region, 2022 (%)

Other regions such as North America, Middle East and Africa, Asia Pacific, Europe in process to contribute the market share with increasing demands for point-of-care testing with increasing disorder with enhance market size. 

Recent Developments

  • In the year 2018 December, Anteo Diagnostics of Australia collaborated with Shanghai GeneoDx Biotechnology of china introduced the AnteoBind products with an agreement of sell and distribution of product in china.
  • In the year 2017 January, Chembio Diagnostics Inc, (US) adopt the RVR diagnostics and expansion of the products with increased offers and availability of product in Southeast Asia.
  • In the year 2016 March, Collaboration of Chembio Diagnostics Inc and BioManguinhos/Fiocruz (Brazil) for the development of Point-of-care diagnostic kit with the new launch of Zika test.

Segments Covered in the Report

By Product Type

  • Covid -19 testing kits
  • Glucose monitoring products
    • Meters
    • Strips
    • Lancets and Lancing devices
  • Cardiometabolic Monitoring Products
    • Cardiac maker testing products
    • Blood Gas / Electrolyte testing products
    • HbA1c testing products
  • Infectious disease testing products
    • Influenza testing products
    • HIV testing products
    • Hepatitis testing products
    • Sexually Transmitted Diseases testing products
    • Healthcare - associated Infection testing products
    • Respiratory infection testing products
    • Tropical disease testing products
    • others
  • Coagulation monitoring products
    • PT / INR testing
    • ACT / APTT
  • Pregnancy and fertility testing products
  • Pregnancy testing products
  • Fertility testing products
  • Cancer marker testing products
  • Urinanalysis testing products
  • Cholestrol testing products
  • Hematology testing products
  • Drugs-of-abuse testing products
  • Fecal Occult testing products
  • Others

By Platform

By Mode of Purchase

  • OTC products
  • Prescribed based products

By Testing Type

  • Immunoassays
  • Cell-Based Assays
  • Nucleic Acid Amplification Testing
  • Clinical Chemistry Assays
  • Hematology 

By End-User

  • Clinical laboratories
  • Ambulatory care facilities and physician offices
  • Pharmacies, retail clinics & E-comm platforms
  • Hospitals, Critical care centres, Urgent care centres
  • Home care & self-testing
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global point-of-care testing (POCT) market size was accounted at USD 35.33 billion in 2023 and it is expected to reach around USD 99.33 billion by 2032.

The global point-of-care testing (POCT) market is poised to grow at a CAGR of 12.2% from 2023 to 2032.

The major players operating in the point-of-care testing (POCT) market are Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc

Increasing prevalence of chronic disorders, increased R&D with new innovative techniques and developing infrastructure & healthcare facilities these are driving the growth of the point-of-care testing (POCT) market.

North America region will lead the global point-of-care testing (POCT) market during the forecast period 2023 to 2032.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client